SEC Form 4 · accession 0001209191-15-056467

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Lewis Clayton Cantley Jr.

Director

Period of report

Jun 23, 2015

Accepted (ET)

Jun 25, 2015 · 6:22 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001439222

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common stock^F2	Jun 24, 2015	S	2,426	$104.60	D	164,836	D
Common stock^F3,F4	Jun 24, 2015	S	2,426	$104.59	D	164,836	I	See footnote
Common stock^F5	Jun 25, 2015	S	2,426	$105.66	D	162,410	D
Common stock^F6,F4	Jun 25, 2015	S	2,426	$105.66	D	162,410	I	See footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock option (right to buy)^F7	$103.63	Jun 23, 2015	A	10,625	A	—	Jun 22, 2025	Common stock	10,625	168,579	D

Explanation of responses

F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $103.00 to $105.97. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $103.00 to $106.47. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4Shares held by Vicki Lee Sato, who is the reporting person's spouse.
F5The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.82 to $107.30. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.82 to $107.28. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7This option was granted on June 23, 2015. The shares underlying this option vest as to 100% of the underlying shares on June 23, 2016.